$14.67
0.44[3.09%]
At close: Apr 19
$14.67
0[0.00%]
After Hours: 4:00PM EDT
Deciphera Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Deciphera Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | AM | DCPH | Q1 | -$0.60 | -$0.55 | — | — | $33.45M | $46.08M | — | — | Get Alert |
02/06/2024 | AM | DCPH | Q4 | -$0.60 | -$0.58 | -$0.54 | 6.90% | $36.34M | $45.92M | $48.30M | 5.17% | Get Alert |
10/30/2023 | AM | DCPH | Q3 | -$0.55 | -$0.61 | -$0.58 | 4.92% | $35.97M | $39.35M | $43.31M | 10.07% | Get Alert |
08/09/2023 | AM | DCPH | Q2 | -$0.60 | -$0.62 | -$0.57 | 8.06% | $32.49M | $35.88M | $38.30M | 6.76% | Get Alert |
05/03/2023 | AM | DCPH | Q1 | -$0.80 | -$0.59 | -$0.60 | -1.69% | $29.22M | $35.80M | $33.45M | -6.58% | Get Alert |
02/07/2023 | AM | DCPH | Q4 | -$1.51 | -$0.56 | -$0.60 | -7.14% | $24.20M | $35.75M | $36.34M | 1.66% | Get Alert |
11/03/2022 | AM | DCPH | Q3 | -$1.37 | -$0.58 | -$0.55 | 5.17% | $23.22M | $33.15M | $35.97M | 8.52% | Get Alert |
08/04/2022 | AM | DCPH | Q2 | -$1.21 | -$0.66 | -$0.60 | 9.09% | $23.57M | — | $32.49M | — | Get Alert |
05/04/2022 | AM | DCPH | Q1 | -$1.06 | — | -$0.80 | — | $25.16M | $26.43M | $29.22M | 10.57% | Get Alert |
02/08/2022 | PM | DCPH | Q4 | -$1.10 | — | -$1.51 | — | $19.49M | — | $24.20M | — | Get Alert |
11/02/2021 | PM | DCPH | Q3 | -$1.13 | -$1.28 | -$1.37 | -7.03% | $15.45M | $23.36M | $23.22M | -0.60% | Get Alert |
08/03/2021 | PM | DCPH | Q2 | -$1.20 | -$1.15 | -$1.21 | -5.22% | $7.09M | $22.00M | $23.57M | 7.15% | Get Alert |
05/04/2021 | PM | DCPH | Q1 | -$1.36 | -$1.07 | -$1.06 | 0.93% | $62.00K | $22.41M | $25.16M | 12.25% | Get Alert |
02/09/2021 | PM | DCPH | Q4 | -$1.31 | -$1.15 | -$1.10 | 4.35% | $0.00 | $18.93M | $19.49M | 2.94% | Get Alert |
11/05/2020 | PM | DCPH | Q3 | -$1.28 | -$1.30 | -$1.13 | 13.08% | — | $7.05M | $15.45M | 119.13% | Get Alert |
08/04/2020 | PM | DCPH | Q2 | -$0.56 | -$1.37 | -$1.20 | 12.41% | $25.00M | $900.00K | $7.09M | 687.78% | Get Alert |
05/05/2020 | PM | DCPH | Q1 | -$1.25 | -$1.25 | -$1.36 | -8.80% | $0.00 | $210.00K | $62.00K | -70.48% | Get Alert |
03/09/2020 | PM | DCPH | Q4 | -$0.86 | -$1.18 | -$1.31 | -11.02% | $0.00 | $1.15M | $0.00 | -100.00% | Get Alert |
11/04/2019 | PM | DCPH | Q3 | -$0.65 | -$1.16 | -$1.28 | -10.34% | $0.00 | $132.10M | $0.00 | -100.00% | Get Alert |
Deciphera Pharmaceuticals (DCPH) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 6, 2024 for Q4.
The Actual EPS was $-0.54, which beat the estimate of $-0.58.
The Actual Revenue was $48.3M, which beat the estimate of $45.9M.
Browse earnings estimates, EPS, and revenue on all stocks.